Research Library
-
Evidence & Quality Guides
From peptide API to clinical formulation: why handovers can delay a project
-
Evidence & Quality Guides
Peptide factory expansion: why usable output does not increase immediately
-
Published Study Reviews
Glutathione exposure increased about 2.5-fold: why formulation and dose both matter
-
Published Study Reviews
Tesamorelin plus exercise: understanding the TRIUMPH trial protocol in older adults with HIV
-
Published Study Reviews
Tesamorelin and cognition: what a 22-person trial can and cannot show
-
Published Study Reviews
PEG-modified thymosin beta-4: why study how long it stays in the body?
-
Published Study Reviews
Thymosin beta-4 microneedles: why does fabrication temperature matter?
-
Published Study Reviews
Thymosin beta-4 and intestinal inflammation: why also measure fibrosis?
-
Published Study Reviews
BPC-157 in human artery tissue: why this was not a patient treatment trial
-
Published Study Reviews
Adding sugar to an LL-37 fragment: what changes did researchers investigate?
-
Published Study Reviews
Modified LL-37 peptides: how structural changes affected tuberculosis bacteria
-
Published Study Reviews
SS-31 and oocyte maturation: what did the October study actually test?